��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
上福(6128)
月營收
季盈餘
2025/03/01
36.55元 (上福股價)
2025/03/01
1.74% (年增率)
474百萬元 (營收)
上福(6128) 年度營收走勢圖
上福(6128)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/03
473,902
11.21%
465,800
1.74%
1,354,299
-1.46%
114/02
426,125
-6.20%
456,755
-6.71%
880,397
-3.11%
114/01
454,272
6.84%
451,861
0.53%
454,272
0.53%
113/12
425,191
-6.80%
416,635
2.05%
5,510,051
3.70%
113/11
456,207
-10.04%
459,567
-0.73%
5,084,859
3.84%
113/10
507,131
4.26%
455,298
11.38%
4,628,652
4.31%
113/09
486,426
21.60%
484,721
0.35%
4,121,521
3.51%
113/08
400,024
-14.83%
414,499
-3.49%
3,635,095
3.94%
113/07
469,702
3.58%
398,734
17.80%
3,235,071
4.94%
113/06
453,477
-7.12%
463,133
-2.08%
2,765,369
3.03%
113/05
488,243
8.68%
453,336
7.70%
2,311,892
4.10%
113/04
449,233
-3.56%
397,973
12.88%
1,823,649
3.18%
113/03
465,800
1.98%
505,283
-7.81%
1,374,416
0.36%
113/02
456,755
1.08%
424,899
7.50%
908,616
5.13%
113/01
451,861
8.45%
439,342
2.85%
451,861
2.85%
112/12
416,635
-9.34%
409,634
1.71%
5,313,420
-6.84%
112/11
459,567
0.94%
475,905
-3.43%
4,896,784
-7.50%
112/10
455,298
-6.07%
454,523
0.17%
4,437,218
-7.91%
112/09
484,721
16.94%
468,330
3.50%
3,981,920
-8.75%
112/08
414,499
3.95%
436,810
-5.11%
3,497,199
-10.22%
112/07
398,734
-13.91%
423,073
-5.75%
3,082,700
-10.87%
112/06
463,133
2.16%
510,350
-9.25%
2,683,966
-11.58%
112/05
453,336
13.91%
552,201
-17.90%
2,220,833
-12.05%
112/04
397,973
-21.24%
481,064
-17.27%
1,767,497
-10.41%
112/03
505,283
18.92%
590,441
-14.42%
1,369,524
-8.20%
112/02
424,899
-3.29%
452,325
-6.06%
864,241
-4.12%
112/01
439,342
7.25%
449,054
-2.16%
439,342
-2.16%
111/12
409,634
-13.93%
457,246
-10.41%
5,703,710
15.86%
111/11
475,905
4.70%
486,537
-2.19%
5,294,076
18.55%
111/10
454,523
-2.95%
474,641
-4.24%
4,818,171
21.09%
111/09
468,330
7.22%
448,819
4.35%
4,363,648
24.52%
111/08
436,810
3.25%
320,197
36.42%
3,895,318
27.48%
111/07
423,073
-17.10%
360,322
17.42%
3,458,508
26.44%
111/06
510,350
-7.58%
411,020
24.17%
3,035,435
27.81%
111/05
552,201
14.79%
403,868
36.73%
2,525,085
28.57%
111/04
481,064
-18.52%
401,770
19.74%
1,972,884
26.45%
111/03
590,441
30.53%
423,054
39.57%
1,491,820
28.78%
111/02
452,325
0.73%
901,379
111/01
449,054
-1.79%
449,054
110/12
457,246
-6.02%
4,922,807
110/11
486,537
2.51%
4,465,561
110/10
474,641
5.75%
3,979,024
110/09
448,819
40.17%
3,504,383
110/08
320,197
-11.14%
3,055,564
110/07
360,322
-12.33%
2,735,367
110/06
411,020
1.77%
2,375,045
110/05
403,868
0.52%
1,964,025
110/04
401,770
-5.03%
1,560,157
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
